Agile Therapeutics Inc(AGRX) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Agile Therapeutics, Inc., a women's healthcare company, focuses on the research, development, and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter and lighter periods; AG200-ER (SmP), a regimen to allow a woman to extend the length of her cycle, as well as experience shorter and lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Current Price

$1.49

RSI

13.783

Beta:

1.050193

March 01, 2021
16.6M
-17.4M

-192.642 %
-79.920 %

$749,000
$0
$0
$0
$0
$0
100.000 %
%
%
%
0.000 %

$-51,853,000
$-18,606,000
$-20,256,000
$-28,304,000
$-31,816,000
$-36,307,000
-64.118 %
8.868 %
39.731 %
12.408 %
14.116 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.